Pancreatic neuroendocrine tumor classification: Difference between revisions
Shanshan Cen (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{PleaseHelp}} ==References== {{Reflist|2}}") |
Shanshan Cen (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pancreatic neuroendocrine tumor}} | |||
{{CMG}} | {{CMG}} | ||
==Types== | |||
PanNETs are sometimes abbreviated as PETs or PNETs: such use should not to be confused with the [[primitive neuroectodermal tumor]] (PNET). | |||
The majority of PanNETs are [[benign]], while some are [[malignant]]. The World Health Organization (WHO) classification scheme places neuroendocrine tumors into three main categories, which emphasize the [[Grading (tumors)|tumor grade]] rather than the [[anatomy|anatomical origin]]. In practice, those tumors termed well or intermediately [[Grading (tumors)|differentiated]] PanNETs in the WHO scheme are sometimes called "[[islet cell]] tumors." The high grade subtype, termed neuroendocrine cancer (NEC) in the WHO scheme, is synonymous with "islet cell carcinoma". | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 18:53, 17 August 2015
|
Pancreatic neuroendocrine tumor Microchapters |
|
Differentiating Pancreatic neuroendocrine tumor from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pancreatic neuroendocrine tumor classification On the Web |
|
American Roentgen Ray Society Images of Pancreatic neuroendocrine tumor classification |
|
Directions to Hospitals Treating Pancreatic neuroendocrine tumor |
|
Risk calculators and risk factors for Pancreatic neuroendocrine tumor classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Types
PanNETs are sometimes abbreviated as PETs or PNETs: such use should not to be confused with the primitive neuroectodermal tumor (PNET).
The majority of PanNETs are benign, while some are malignant. The World Health Organization (WHO) classification scheme places neuroendocrine tumors into three main categories, which emphasize the tumor grade rather than the anatomical origin. In practice, those tumors termed well or intermediately differentiated PanNETs in the WHO scheme are sometimes called "islet cell tumors." The high grade subtype, termed neuroendocrine cancer (NEC) in the WHO scheme, is synonymous with "islet cell carcinoma".